New Delhi metallo-beta-lactamase-1: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
No edit summary
imported>Howard C. Berkowitz
No edit summary
Line 13: Line 13:
  | url = http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1198-743X&date=2002&volume=8&issue=6&spage=321}}</ref> These organisms often are also resistant to [[quinolone|fluoroquinolone]]s and [[aminoglycoside]]s.
  | url = http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1198-743X&date=2002&volume=8&issue=6&spage=321}}</ref> These organisms often are also resistant to [[quinolone|fluoroquinolone]]s and [[aminoglycoside]]s.


First reported in ''[[Klebsiella pneumoniae]]'', it has been reported in ''[[Acinetobacter baumanii]],  [[Escherichia  coli]], [[Citrobacter freundii]], [[Enterobacter cloacae]]'', and ''[[Morganella morganii]]''.  A number of cases have been found in Britain, Canada and the US in patients that went to India for medical procedures or were treated for emergencies while in India.<ref>{{citation
First reported in ''[[Klebsiella pneumoniae]]'', it has been reported in ''[[Acinetobacter]],  [[Escherichia  coli]], [[Citrobacter freundii]], [[Enterobacter cloacae]]'', and ''[[Morganella morganii]]''.  A number of cases have been found in Britain, Canada and the US in patients that went to India for medical procedures or were treated for emergencies while in India.<ref>{{citation
  | title = NDM-1 carrying Enterobacteriaceae - worldwide ex India, Pakistan (02)
  | title = NDM-1 carrying Enterobacteriaceae - worldwide ex India, Pakistan (02)
  | journal = ProMED Emerging Disease Report, International Society for Infectious Diseases
  | journal = ProMED Emerging Disease Report, International Society for Infectious Diseases

Revision as of 17:35, 14 September 2010

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

New Delhi metallo-beta-lactamase-1 enzyme confers bacterial resistance to antibiotics of the carbepenem class, often considered "last resort" drugs for multidrug resistant bacteria.[1] The gene to manufacture it can be horizontally transferred among different species of pathogenic bacteria.

Organisms that produce the enzyme are resistant to virtually all beta-lactam antibiotics except azneotram. [2] These organisms often are also resistant to fluoroquinolones and aminoglycosides.

First reported in Klebsiella pneumoniae, it has been reported in Acinetobacter, Escherichia coli, Citrobacter freundii, Enterobacter cloacae, and Morganella morganii. A number of cases have been found in Britain, Canada and the US in patients that went to India for medical procedures or were treated for emergencies while in India.[3]

References

  1. Krishna B (2010 [cited 2010 Sep 14]), "New Delhi metallo-beta-lactamases: A wake-up call for microbiologists", Indian J Med Microbiol [serial online] 28: 265-6.
  2. >Nordmann P, Poirel L. (2002), "Emerging carbapenemases in Gram-negative aerobes", Clin Microbiol Infect 8: 321-31
  3. "NDM-1 carrying Enterobacteriaceae - worldwide ex India, Pakistan (02)", ProMED Emerging Disease Report, International Society for Infectious Diseases, 14 September 2010